Thyroidectomy as Primary Treatment Optimizes Body Mass Index in Patients with Hyperthyroidism

被引:7
|
作者
Schneider, David F. [1 ]
Nookala, Ratnam [2 ]
Jaraczewski, Taylor J. [1 ]
Chen, Herbert [1 ]
Solorzano, Carmen C. [2 ]
Sippel, Rebecca S. [1 ]
机构
[1] Univ Wisconsin, Dept Surg, Madison, WI 53706 USA
[2] Vanderbilt Univ, Dept Surg, Med Ctr, Div Surg Oncol & Endocrine Surg, Nashville, TN 37240 USA
基金
美国国家卫生研究院;
关键词
GAIN FOLLOWING TREATMENT; GRAVES-DISEASE; WEIGHT-GAIN; ENERGY-EXPENDITURE; MULTINODULAR GOITER; SERUM LEPTIN; OBESITY; MANAGEMENT; WOMEN; SURGERY;
D O I
10.1245/s10434-014-3542-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to determine how the timing of thyroidectomy influenced postoperative weight change. We conducted a two-institution study, identifying patients treated with total thyroidectomy for hyperthyroidism. Patients were classified as 'early' if they were referred for surgery as the first treatment option, or 'delayed' if they were previously treated with radioactive iodine (RAI). Groups were compared with the Student's t-test or chi (2) test where appropriate. There were 204 patients undergoing thyroidectomy for hyperthyroidism. Of these, 171 patients were classified as early and 33 were classified as delayed. Overall, patients gained 6.0 % +/- 0.8 of their preoperative body weight at last follow-up. Preoperative body mass indexes (BMIs) were similar between groups (p = 0.98), and the median follow-up time was 388 days (range 15-1,584 days). Both groups gained weight until they achieved a normal thyroid-stimulating hormone (TSH) postoperatively. After achieving a normal TSH, the early group stabilized or lost weight (-0.2 lbs/day), while the delayed group continued to gain weight (0.02 lbs/day; p = 0.61). At last follow-up, there were significantly more patients in the delayed group who increased their BMI category compared with the early group (42.4 vs. 21.6 %; p = 0.01). Twice as many patients in the delayed group moved up or into an unhealthy BMI category (overweight or obese) compared with the early group (39.4 vs. 19.3 %; p = 0.01). Compared with patients initially treated with RAI, patients with hyperthyroidism who underwent surgery as the first treatment were less likely to become overweight or obese postoperatively.
引用
收藏
页码:2303 / 2309
页数:7
相关论文
共 50 条
  • [41] PROBLEM OF THYROIDECTOMY IN PATIENTS WITH HYPERTHYROIDISM AND ASSOCIATED MYASTHENIA GRAVIS
    ROOT, GT
    JERNIGAN, SK
    WALLER, E
    CHRISTENSEN, BH
    ARCHIVES OF SURGERY, 1962, 85 (02) : 324 - 328
  • [42] Association of Body Mass Index and Body Mass Index Change with Mortality in Incident Peritoneal Dialysis Patients
    Xiong, Liping
    Cao, Shirong
    Xu, Fenghua
    Zhou, Qian
    Fan, Li
    Xu, Qingdong
    Yu, Xueqing
    Mao, Haiping
    NUTRIENTS, 2015, 7 (10) : 8444 - 8455
  • [43] Body Mass Index and Survival of Patients with Lymphoma
    Chihara, Dai
    Larson, Melissa C.
    Robinson, Dennis P.
    Thompson, Carrie A.
    Maurer, Matthew J.
    Casulo, Carla
    Link, Brian K.
    Habermann, Thomas M.
    Feldman, Andrew L.
    Flowers, Christopher
    Cerhan, James R.
    Morton, Lindsay M.
    BLOOD, 2020, 136
  • [44] Impact of the body mass index in patients with mastocytosis
    Gorska, A.
    Gruchala-Niedoszytko, M.
    Lange, M.
    Niedoszytko, M.
    Valent, P.
    Brockow, K.
    Gotlib, J.
    Triggiani, M.
    Sperr, W. R.
    Elberink, H. O.
    Hartmann, K.
    Gleixner, K., V
    Bonifacio, M.
    Bonadonna, P.
    Zanotti, R.
    Arock, M.
    Hermine, O.
    Sabato, V
    Aberer, E.
    Van Anrooij, B.
    Reiter, A.
    Doubek, M.
    ALLERGY, 2019, 74 : 424 - 425
  • [45] Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer
    Takada, Masahiro
    Saji, Shigehira
    Masuda, Norikazu
    Kuroi, Katsumasa
    Sato, Nobuaki
    Takei, Hiroyuki
    Yamamoto, Yutaka
    Ohno, Shinji
    Yamashita, Hiroko
    Hisamatsu, Kazufumi
    Aogi, Kenjiro
    Iwata, Hiroji
    Ueno, Takayuki
    Sasano, Hironobu
    Toi, Masakazu
    BREAST, 2012, 21 (01): : 40 - 45
  • [46] Body mass index and survival of patients with lymphoma
    Chihara, Dai
    Larson, Melissa C.
    Robinson, Dennis P.
    Thompson, Carrie A.
    Maurer, Matthew J.
    Casulo, Carla
    Pophali, Priyanka
    Link, Brian K.
    Habermann, Thomas M.
    Feldman, Andrew L.
    Flowers, Christopher R.
    Cerhan, James R.
    Morton, Lindsay M.
    LEUKEMIA & LYMPHOMA, 2021, 62 (11) : 2671 - 2678
  • [47] Body mass index in patients with unusual proportions
    Garn, SM
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 66 (05): : 1294 - 1295
  • [48] Body mass index and body surface area in scleroderma patients
    Wcislo-Dziadecka, D.
    Kazmierczak, A.
    Zbiciak-Nylec, M.
    Brzoza, Z.
    Brzezinska-Wcislo, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (05) : E164 - E165
  • [49] RADIOIODINE TREATMENT OF RECURRENT HYPERTHYROIDISM IN PATIENTS PREVIOUSLY TREATED FOR GRAVES-DISEASE BY SUBTOTAL THYROIDECTOMY
    VESTERGAARD, H
    LAURBERG, P
    JOURNAL OF INTERNAL MEDICINE, 1992, 231 (01) : 13 - 17
  • [50] Predictors of Treatment Outcome in Persons With Anorexia Nervosa: On the Practice of Regressing Body Mass Index at the End of Treatment on Body Mass Index at Baseline
    Meule, Adrian
    Kolar, David R.
    Voderholzer, Ulrich
    INTERNATIONAL JOURNAL OF EATING DISORDERS, 2025, 58 (01) : 254 - 258